Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. The company is headquartered in Hollister, California and currently employs 173 full-time employees. The company went IPO on 2021-06-25. The company offers two primary product categories, which include lab essentials and clinical solutions. The company also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The firm offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. The company supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.
Follow-Up Questions
Who is the CEO of Alpha Teknova Inc?
Mr. Stephen Gunstream is the President of Alpha Teknova Inc, joining the firm since 2019.
What is the price performance of TKNO stock?
The current price of TKNO is $5.11, it has decreased 0.37% in the last trading day.
What are the primary business themes or industries for Alpha Teknova Inc?
Alpha Teknova Inc belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is Alpha Teknova Inc market cap?
Alpha Teknova Inc's current market cap is $273.5M
Is Alpha Teknova Inc a buy, sell, or hold?
According to wall street analysts, 5 analysts have made analyst ratings for Alpha Teknova Inc, including 4 strong buy, 5 buy, 3 hold, 0 sell, and 4 strong sell
